Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 11/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 8/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 8/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 7/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5764321 | 1.00 | ADORA2A (0.49) | ADORA2ATSHRADORA3ADORA1ADORA2B | |
| SCHEMBL5764097 | 0.91 | ADORA2A (0.59) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL5764105 | 0.91 | ADORA2A (0.59) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL5761864 | 0.88 | ADORA3 (0.59) | ADORA2ATSHRADORA3ADORA1ADORA2B | |
| SCHEMBL5764226 | 0.88 | ADORA3 (0.59) | ADORA2ATSHRADORA3ADORA1ADORA2B | |
| SCHEMBL5762878 | 0.80 | ADORA2A (0.73) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL5764746 | 0.80 | ADORA2A (0.73) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL5764752 | 0.80 | ADORA2A (0.73) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL7213320 | 0.78 | ADORA2A (0.45) | ADORA2AADORA3ADORA1ADORA2B | |
| SCHEMBL7070058 | 0.78 | ADORA2A (0.45) | ADORA2AADORA3ADORA1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1220862-B1 | PURINE DERIVATIVES | PFIZER LTD (GB) | 2006-03-22 | — | — | EP | disclosed |
| US-6448236-B1 | FUNCTIONAL AGONISTS OF THE HUMAN ADENOSINE A2A RECEPTOR AND MAY BE USED AS, FOR EXAMPLE, ANTI-INFLAMMATORY AGENTS IN THE TREATMENT OF REPIRATORY DISEASES | PFIZER INC | 2002-09-10 | — | — | US | disclosed |